For people with weakened immune systems, the question of how to stay safe from COVID-19 is especially urgent. A new report from the United States has taken a closer look at this exact problem, reviewing what we know about preventing and treating the virus in immunocompromised individuals. The report doesn't present new research findings or clinical trial results. Instead, it serves as a focused examination of the existing landscape for a group that remains at higher risk. Because this is a review and not a new study, it doesn't offer breakthrough data or clear-cut recommendations. It highlights the ongoing need for tailored strategies but doesn't specify what those are or how well they work. The lack of reported results means we're still waiting for concrete evidence on the most effective approaches for this community.
How can immunocompromised people protect themselves from COVID-19?
Photo by Navy Medicine / Unsplash
What this means for you:
A report reviews COVID-19 care for immunocompromised people, but new answers are still needed. More on COVID-19
Clozapine Use Linked to Higher SARS-CoV-2 Infection Risk in Severe Mental Disorders Clozapine users faced higher risk of severe COVID-19 in large study
· May 1, 2026
Metformin, fluvoxamine, or ivermectin for non-hospitalized COVID-19 adults in a Phase 3 trial Metformin Cuts Long Covid Risk by 40%
CT.gov · Apr 24, 2026
Observational cohort study on SARS-CoV-2 evolution in immunocompromised patients Long COVID Virus Changes Shape Inside Severely Ill Patients, Study Finds
medRxiv · Apr 19, 2026
Systematic review synthesizes immune and genetic factors in African SARS-CoV-2 populations Why Africa saw milder COVID-19
Frontiers · Apr 15, 2026